Nanollose
- Short interest
- <0.01%
- 0.00 pp 30d
- as of 16 Nov 2026
- Reported shorts
- 1.2K
- Shares on issue
- 409.827M
Latest articles and price-sensitive announcements with AI sentiment classification.
Highlights Operating within the innovative ASX biotechnology, medical technology, and healthcare services sectors, the company navigates a demanding operating landscape shaped by clinical development complexity, international regulations, and disciplined treasury management. Operationally, management has directed executive focus and capital resources toward partnering with global textile and fashion conglomerates to commercialize microbial cellulose fibers. From a broader commercial perspective...
other announcement
other announcement
other announcement
Nanollose Limited (ASX:NC6) has issued 132,857 unlisted options with an exercise price of $0.05, set to expire on 8 October 2028. The company revealed these securities were granted as payment for consultancy services instead of cash fees, as detailed in an Appendix 3G filing dated 8 October 2026. Key Points Issued 132,857 unlisted options on 8 October 2026, expiring 8 October 2028 with an exercise price of AUD $0.05 Options granted in exchange for consultancy services rendered in lieu of cash...
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement